Twelve derivatives 1a-1m of the β-crinane-type alkaloid haemanthamine were developed. All the semisynthetic derivatives were studied for their inhibitory potential against both acetylcholinesterase and butyrylcholinesterase. In addition, glycogen synthase kinase 3β (GSK-3β) inhibition potency was evaluated in the active derivatives. In order to reveal the availability of the drugs to the CNS, we elucidated the potential of selected derivatives to penetrate through the blood-brain barrier (BBB). Two compounds, namely 11-O-(2-methylbenzoyl)-haemanthamine (1j) and 11-O-(4-nitrobenzoyl)-haemanthamine (1m), revealed the most intriguing profile, both being acetylcholinesterase (hAChE) inhibitors on a micromolar scale, with GSK-3β inhibition properties, and predicted permeation through the BBB. In vitro data were further corroborated by detailed inspection of the compounds' plausible binding modes in the active sites of hAChE and hBuChE, which led us to provide the structural determinants responsible for the activity towards these enzymes.

ADINACO Research Group Department of Pharmaceutical Botany Faculty of Pharmacy Charles University Heyrovského 1203 500 05 Hradec Králové Czech Republic

ADINACO Research Group Department of Pharmaceutical Botany Faculty of Pharmacy Charles University Heyrovského 1203 500 05 Hradec Králové Czech Republic Department of Pharmacognosy Faculty of Pharmacy Charles University Heyrovského 1203 500 05 Hradec Králové Czech Republic

Centro de Investigaciones Biológicas CSIC Avenida Ramiro de Maeztu 9 28040 Madrid Spain

Deaprtment of Biological and Biochemical Sciences Faculty of Chemical Technology University of Pardubice Studentská 95 532 10 Pardubice Czech Republic

Department for Life Quality Studies University of Bologna Corso D'Augusto 237 47921 Rimini Italy

Department of Analytical Chemistry Faculty of Pharmacy Charles University Heyrovského 1203 500 05 Hradec Králové Czech Republic

Department of Medicinal Biochemistry Faculty of Medicine Charles University Zborovská 2089 500 03 Hradec Králové Czech Republic

Department of Organic and Bioorganic Chemistry Faculty of Pharmacy Charles University Heyrovského 1203 500 05 Hradec Králové Czech Republic

Department of Toxicoloxy and Military Pharmacy Faculty of Military Health Sciences University of Defence Třebešská 1575 500 05 Hradec Králové Czech Republic

Department of Toxicoloxy and Military Pharmacy Faculty of Military Health Sciences University of Defence Třebešská 1575 500 05 Hradec Králové Czech Republic Department Biomedical Research Centre University Hospital Hradec Kralove Sokolska 581 500 05 Hradec Králové Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc19034624

003      

CZ-PrNML

005      

20191008104727.0

007      

ta

008      

191007s2019 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3390/molecules24071307 $2 doi

035    __

$a (PubMed)30987121

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Kohelová, Eliška $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. kohelove@faf.cuni.cz.

245    10

$a Derivatives of the β-Crinane Amaryllidaceae Alkaloid Haemanthamine as Multi-Target Directed Ligands for Alzheimer's Disease / $c E. Kohelová, R. Peřinová, N. Maafi, J. Korábečný, D. Hulcová, J. Maříková, T. Kučera, L. Martínez González, M. Hrabinova, K. Vorčáková, L. Nováková, A. De Simone, R. Havelek, L. Cahlíková,

520    9_

$a Twelve derivatives 1a-1m of the β-crinane-type alkaloid haemanthamine were developed. All the semisynthetic derivatives were studied for their inhibitory potential against both acetylcholinesterase and butyrylcholinesterase. In addition, glycogen synthase kinase 3β (GSK-3β) inhibition potency was evaluated in the active derivatives. In order to reveal the availability of the drugs to the CNS, we elucidated the potential of selected derivatives to penetrate through the blood-brain barrier (BBB). Two compounds, namely 11-O-(2-methylbenzoyl)-haemanthamine (1j) and 11-O-(4-nitrobenzoyl)-haemanthamine (1m), revealed the most intriguing profile, both being acetylcholinesterase (hAChE) inhibitors on a micromolar scale, with GSK-3β inhibition properties, and predicted permeation through the BBB. In vitro data were further corroborated by detailed inspection of the compounds' plausible binding modes in the active sites of hAChE and hBuChE, which led us to provide the structural determinants responsible for the activity towards these enzymes.

650    _2

$a Alzheimerova nemoc $x metabolismus $7 D000544

650    _2

$a Amaryllidaceae $x chemie $x metabolismus $7 D000070378

650    _2

$a alkaloidy amarylkovitých $x chemie $x metabolismus $7 D047151

650    _2

$a hematoencefalická bariéra $x metabolismus $7 D001812

650    _2

$a GSK3B $x metabolismus $7 D000071679

650    _2

$a lidé $7 D006801

650    _2

$a ligandy $7 D008024

650    _2

$a molekulární modely $7 D008958

650    _2

$a molekulární konformace $7 D008968

650    _2

$a simulace molekulového dockingu $7 D062105

650    _2

$a molekulární struktura $7 D015394

650    _2

$a permeabilita $7 D010539

650    _2

$a fenantridiny $x chemie $x metabolismus $7 D010617

650    _2

$a vztahy mezi strukturou a aktivitou $7 D013329

655    _2

$a časopisecké články $7 D016428

700    1_

$a Peřinová, Rozálie $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. perinovr@faf.cuni.cz.

700    1_

$a Maafi, Negar $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. negarm@faf.cuni.cz.

700    1_

$a Korábečný, Jan $u Department of Toxicoloxy and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Třebešská 1575, 500 05 Hradec Králové, Czech Republic. korabecny.jan1@gmail.com. Department Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Králové, Czech Republic. korabecny.jan1@gmail.com.

700    1_

$a Hulcová, Daniela $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. hulcovd@faf.cuni.cz. Department of Pharmacognosy, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. hulcovd@faf.cuni.cz.

700    1_

$a Maříková, Jana $u Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. marikoj2@faf.cuni.cz.

700    1_

$a Kučera, Tomáš $u Department of Toxicoloxy and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Třebešská 1575, 500 05 Hradec Králové, Czech Republic. tomas.kucera2@unob.cz.

700    1_

$a Martínez González, Loreto $u Centro de Investigaciones Biológicas-CSIC, Avenida Ramiro de Maeztu 9, 28040 Madrid, Spain. loretomg@cib.csic.es.

700    1_

$a Hrabinova, Martina $u Department of Toxicoloxy and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Třebešská 1575, 500 05 Hradec Králové, Czech Republic. hrabinova@pmfhk.cz.

700    1_

$a Vorčáková, Katarina $u Deaprtment of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentská 95, 532 10 Pardubice, Czech Republic. katarina.vorcakova@upce.cz.

700    1_

$a Nováková, Lucie $u Department of Analytical Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. novakoval@faf.cuni.cz.

700    1_

$a De Simone, Angela $u Department for Life Quality Studies, University of Bologna, Corso D'Augusto 237, 47921 Rimini, Italy. angela.desimone2@unibo.it.

700    1_

$a Havelek, Radim $u Department of Medicinal Biochemistry, Faculty of Medicine, Charles University, Zborovská 2089, 500 03 Hradec Králové, Czech Republic. havelekr@lfhk.cuni.cz.

700    1_

$a Cahlíková, Lucie $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. cahlikova@faf.cuni.cz.

773    0_

$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 24, č. 7 (2019)

856    41

$u https://pubmed.ncbi.nlm.nih.gov/30987121 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20191007 $b ABA008

991    __

$a 20191008105144 $b ABA008

999    __

$a ok $b bmc $g 1451284 $s 1073174

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2019 $b 24 $c 7 $e 20190403 $i 1420-3049 $m Molecules $n Molecules $x MED00180394

GRA    __

$a GA UK Nr. 178518, SVV UK 260 412; 260 401; Progres/UK Q40 and Q42 $p Univerzita Karlova v Praze

GRA    __

$a 00179906 $p University Hospital, Hradec Králové

GRA    __

$a CZ.02.1.01/0.0/0.0/18_069/0010046 $p European Union

LZP    __

$a Pubmed-20191007